Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Hepatitis B is the global pandemic no one talks about, yet one in three people worldwide has been infected.
The new once-daily, single-tablet, pangenotypic hepatitis C treatment has the potential to shake things up in the United States and abroad.
An op-ed about viral hepatitis funding compared to funding for Zika virus.
An interview with Dr. Mojca Matičič, Head of the National Viral Hepatitis Expert Group in Slovenia.
An op-ed on what occurs if we disregard the health and welfare of tens of thousands of refugees.
An interview with Charles Gore, chief executive and cofounder of The Hepatitis C Trust and founder of the World Hepatitis Alliance.
Experts believe a cure for hepatitis B will also soon be developed.
An interview with Achim Kautz, special consultant of the European Liver Patients Association and director of the German Liver Help Project
June 6 webinars offering technical assistance for applicants seeking funding for programs for HIV/HCV coinfected people of color
Probuphine promises to deliver six months of continuous buprenorphine treatment. What does this mean for the future of the opioid epidemic?
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
A look at side effects related to hepatitis C treatment
Hepatitis Awareness month is a good start, but we need to do more to save lives
Health and Human Services announces a new viral hepatitis website
Join a Hepatitis Awareness Month Twitter chat about viral hepatitis, particularly in minority communities
With up to 5 million chronic hepatitis C infections in the US, Emalie Huriaux explains why hep C needs to be a national priority